Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing (REMEDY)
COVID-19, Respiratory Disease
About this trial
This is an interventional treatment trial for COVID-19
Eligibility Criteria
Inclusion Criteria: Either hospitalised or non-hospitalised with confirmed COVID-19 acute infection. Received a comprehensive clinical respiratory assessment Persisting (>12 weeks) self-reported breathlessness (on CRQ-D) following COVID-19 and confirmed dysregulated breathing (Nijmegen Questionnaire score NQ >23) Age 18 - 80 years of age Ability to give informed consent Able to understand and speak English language Exclusion Criteria: Severe mood disturbance that limits engagement with the intervention and study outcomes No access to online delivery and/or IT illiterate Significant diagnosed Myalgic Encephalitis/Fibromyalgia/Chronic Fatigue Syndrome prior to developing COVID-19 Severe asthma or other chronic lung disease prior to COVID-19
Sites / Locations
- Nottingham University Hospitals TrustRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Breathing Techniques Intervention
Usual Care
A 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants.
A six week non-intervention (usual care) period will be recruited to, allowing a comparison to the intervention.